News & Updates

Efruxifermin shows therapeutic potential alongside GLP-1RA medications

09 Mar 2024

Treatment with the Fc–FGF21 analogue efruxifermin is well tolerated and appears to further improve liver health in patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis who are already on a GLP-1RA, according to a phase IIb trial.

Efruxifermin shows therapeutic potential alongside GLP-1RA medications

09 Mar 2024

Physical activity boosts mental health in children with neurodevelopmental disorders

08 Mar 2024

Physical activity appears to be beneficial in children and adolescents with different types of neurodevelopmental disorders, with such interventions having positive effects on cognitive function, psychological well-being, internalizing, and externalizing problems, according to the results of a systematic review and meta-analysis.

Physical activity boosts mental health in children with neurodevelopmental disorders

08 Mar 2024

Extreme heat exposure a risk factor for preterm birth

08 Mar 2024 by

Pregnant women who have been exposed to extreme heat have higher chances of delivering their babies before term, while those residing in greener areas are less likely to experience the outcome, according to a study from Australia.

Extreme heat exposure a risk factor for preterm birth

08 Mar 2024

Sugary drinks up CVD risk

08 Mar 2024

People who regularly drink sugar-sweetened beverages (SSBs) are at greater risk of cardiovascular disease (CVD) regardless of their physical activity levels, reports a study.

Sugary drinks up CVD risk

08 Mar 2024

Severe COVID-19 rare in PrEP-treated SARDs patients

08 Mar 2024 by

Breakthrough COVID-19 is not uncommon following pre-exposure prophylaxis (PrEP) with tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases (SARDs), reports a recent study. However, most of the infections in this high-risk population are not severe.

Severe COVID-19 rare in PrEP-treated SARDs patients

08 Mar 2024

Sebetralstat fares well as oral therapy for HAE

08 Mar 2024 by

In the phase III KONFIDENT trial, oral sebetralstat provides rapid symptom relief, cuts treatment burden, and facilitates early treatment in individuals with hereditary angioedema (HAE) attacks.

Sebetralstat fares well as oral therapy for HAE

08 Mar 2024

Computer-aided detection of colonic neoplasia yields modest improvements

08 Mar 2024

The use of real-time, computer-aided detection of colonic neoplasia leads to modest increases in adenoma detection rate and adenomas detected per colonoscopy in average-detector community endoscopists, as shown in the results of a pragmatic randomized controlled trial.

Computer-aided detection of colonic neoplasia yields modest improvements

08 Mar 2024

Denosumab carries severe hypocalcaemia risk in older female dialysis-dependent patients

07 Mar 2024

In the treatment of osteoporosis among older women who are dialysis-dependent, the use of denosumab appears to result in a much higher incidence of severe and very severe hypocalcaemia when compared with oral bisphosphonates, according to a retrospective cohort study.

Denosumab carries severe hypocalcaemia risk in older female dialysis-dependent patients

07 Mar 2024

Daily oral PrEP regimen remains protective in cisgender women despite missed doses

07 Mar 2024 by

Oral pre-exposure prophylaxis (PrEP) with emtricitabine plus tenofovir disoproxil fumarate (F/TDF) works well to prevent HIV in cisgender women even if daily doses are occasionally missed, according to a study.

Daily oral PrEP regimen remains protective in cisgender women despite missed doses

07 Mar 2024

Pulse vs nonpulse corticosteroid: Which is better against IPF?

07 Mar 2024

Patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) who received a pulse dose of corticosteroids do not appear to have longer survival than those who received conventional nonpulse dose of corticosteroids, results of a study have shown.

Pulse vs nonpulse corticosteroid: Which is better against IPF?

07 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Efruxifermin shows therapeutic potential alongside GLP-1RA medications

Efruxifermin shows therapeutic potential alongside GLP-1RA medications

Physical activity boosts mental health in children with neurodevelopmental disorders

Physical activity boosts mental health in children with neurodevelopmental disorders

Extreme heat exposure a risk factor for preterm birth

Extreme heat exposure a risk factor for preterm birth

Sugary drinks up CVD risk

Sugary drinks up CVD risk

Severe COVID-19 rare in PrEP-treated SARDs patients

Severe COVID-19 rare in PrEP-treated SARDs patients

Sebetralstat fares well as oral therapy for HAE

Sebetralstat fares well as oral therapy for HAE

Computer-aided detection of colonic neoplasia yields modest improvements

Computer-aided detection of colonic neoplasia yields modest improvements

Denosumab carries severe hypocalcaemia risk in older female dialysis-dependent patients

Denosumab carries severe hypocalcaemia risk in older female dialysis-dependent patients

Daily oral PrEP regimen remains protective in cisgender women despite missed doses

Daily oral PrEP regimen remains protective in cisgender women despite missed doses

Pulse vs nonpulse corticosteroid: Which is better against IPF?

Pulse vs nonpulse corticosteroid: Which is better against IPF?